Table 2 |
|||
|
Early or late occurrence of the most frequent aberrations in breast carcinoma |
|||
|
Aberration |
Occurrence in the common precursor (CP) |
Occurrence between the CP and the primary tumor |
Association with early/late events |
|
|
|||
|
+1q |
53% |
13% |
0.050a |
|
-3p |
7% |
13% |
1 |
|
-6q |
40% |
0% |
0.017a |
|
-8p |
60% |
0% |
0.00070c |
|
+8p |
0% |
7% |
1 |
|
+8q |
53% |
0% |
0.0022b |
|
-9p |
27% |
0% |
0.10 |
|
-11q |
20% |
7% |
0.60 |
|
+11q |
0% |
7% |
1 |
|
-14q |
27% |
7% |
0.33 |
|
+16p |
0% |
7% |
1 |
|
-16q |
47% |
7% |
0.035a |
|
-17p |
40% |
20% |
0.43 |
|
+17q |
20% |
13% |
1 |
|
-18p |
7% |
7% |
1 |
|
-18q |
27% |
7% |
0.33 |
|
+20q |
0% |
0% |
1 |
|
|
|||
|
aP ≤ 0.05; bP < 0.01; cP < 0.001; Fisher's exact test. |
|||
|
Letouzé et al. Genome Biology 2010 11:R76 doi:10.1186/gb-2010-11-7-r76 |
|||
